Earnings Call · Q2 FY2025·2025-08-14

Q2 25EPS +98.17%·Rev n/aQ1 25EPS +100.00%*·Rev n/aQ4 24EPS +100.00%*·Rev n/aQ3 24EPS -40.96%·Rev n/a⚠ consensus missing

Traws Pharma, Inc. TRAW

John P. Fraunces — Chief Executive Officer or Host of the Earnings Call

Iain D. Dukes — Chief Operating Officer or Head of Business Development

David Pauza — Medical or Scientific Expert (likely in infectious diseases or virology)

Robert R. Redfield — Infectious Disease Physician, Former Director of the United States Center for Disease Control and Prevention

Charles Parker — Chief Financial Officer or Head of Finance

−1.2%1d on move date−1.2% vs SPY3d−13.4%5d−18.9%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRAW calls or request research access.

More TRAW calls Browse calls Request research access